Ryan Nguyen

There are discrepancies btw the demographics of trials leading to FDA approvals vs the pts we are seeing in clinic @UICancerCenter My colleague @RyanNguyenDO highlights some root causes of disparities & efforts/guidance to improve diversity in clinical trials

@CynthiaXWei @IUCancerCenter @gdurm @IUHemOnc Incredible work! Looking forward to seeing more of your research in the #IRAE space

This research was led by superstar @uiccom med student Zac Hamilton and the Precision Oncology Tumor Board (POTB) team at @UICancerCenter @ShikhaJainMD @FrankWeinbergMD @DrVKGadi

🧬Can #chatgpt generate accurate and relevant #precisiononcology reports for #lungcancer ? 🔎Check out our #asco23 poster 1555 this afternoon which compared ChatGPT treatment rec’s for oncogene driven NSCLC relative to @NCCN guidelines lnkd.in/g3si7bRH

Join a #cancer survivor, a former smoker, and one of our Cancer Center members in a virtual community conversation about #smokingcessation and lung health in recognition of the @AmericanCancer #GreatAmericanSmokeout on Thursday. Register: bit.ly/3hzCiMp

Listen live to @WVON1690 at 10 a.m. (CT) this Sunday to hear @UICancerCenter member @RyanNguyenDO talk about lung health on the "Dr. In The House With Dr. Terry Mason" show. #research #health #cancerresearch bit.ly/3DR23Rd

First day on the job and ⁦@RyanNguyenDO⁩ is kicking some KRAS with fellow Dr. Prescott. Welcome to the team Dr. Nguyen! ⁦⁦@DrLFeldman1⁩ ⁦⁦@ShikhaJainMD⁩ ⁦@UIC_HO_Fellows⁩ ⁦@jillfeldman4⁩ ⁦@TerriConneran⁩ ⁦@KRASKickers⁩

@CPresGeriOncMD @ASCOPost @UICnews @MaryPasquinelli Thank you!

@ASCOPost @RyanNguyenDO @UICnews @MaryPasquinelli Great work!! Keep it up!

Incidental Respiratory Disease Found in Low-Dose CT Screens: Challenges and Opportunities, by Ryan Nguyen, DO, Lawrence E. Feldman, MD, and Mary M. Pasquinelli, DNP, FNP-BC ascopost.com/issues/may-25-… #LDCT #LCSM #COPD #emphysema @RyanNguyenDO @UICnews @MaryPasquinelli

@sTORIof_Life Thank you!!! Appreciate the support

Shout out to @RyanNguyenDO for giving an awesome grand rounds discussing poor representation of Black patients in cancer clinical trials and how allostatic load/chronic stress affects cancer survival and response to cancer treatment. I’m excited for what you’ll accomplish!

There is currently no consensus among professional organizations on the detection, reporting, or management of incidental findings at CT screening for lung cancer ascopost.com/issues/may-25-… via @ascopost @DrLFeldman1 @wittywithmary @UICHemOnc

Proud of our latest published research. Ensuring equitable access with telehealth. Age-based disparities in telehealth use in an urban,... : Journal of the American Association of Nurse Practitioners journals.lww.com/jaanp/Abstract… @cebweldon @JuliaTrosman @JaanpEditor @RyanNguyenDO

@hemoncwarner @JCOCCI_ASCO @dapattmd @ASCO Huge congrats!!!!

It's not your imagination. A cohort study of 3506 patients found Black patients with cancer experienced significantly more severe COVID-19 outcomes. Kudos to authors including @RyanNguyenDO on this @JAMANetworkOpen article. @UICHemOnc bit.ly/3JQ8ncl

Our work on structural racism & AML outcomes is out in @BloodJournal! This was a Chicago-wide collab led by Dr. Abraham & @Irumkhan_hem. The big takeaway - structural racism accounts for almost all of the survival disparity in Black & Hispanic pts #leusm ashpublications.org/blood/article/…

After working on frontlines COVID-19 pandemic in NYC @columbiacancer @nyphospital spring 2020 and case-rate started to decline somewhat, wondered how patients w/ cancer were faring as pandemic swept over space and time. 1/8

Patients with hematologic malignancies are over-represented among vaccinated patients with cancer who develop symptomatic COVID-19. Congratulations to authors including @RyanNguyenDO on this timely @Annals_Oncology paper. @UICHemOnc bit.ly/3HDVTmx

Made it to HOTLANTA ✈️ #ASH21 @YaelSimonsMD @RyanNguyenDO @UIC_HO_Fellows

Our @DrLFeldman1 @MaryPasquinelli @RyanNguyenDO teamed up with colleagues in the @BigTenCRC for this study in Translational #LungCancer Research. They found STK gene mutations point to worse outcomes for #NSCLC patients. @UIowaCancer @IndianaUniv bit.ly/3jP9HBv